Bayer's Expert Mondays
Knowledge Sharing to Empower Your Innovation Journey
Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell & Gene Therapy, Cardiovascular, Immunology, Radiology, and Digital Health!
Do you have that breakthrough innovation in healthcare but bringing that disruptive science to life and navigating entrepreneurial waters is a different beast?
Bayer’s mission is to boost innovation in EMEA and bring it to the patients who need it most. We are looking to enable and support standout innovation in healthcare by providing cost-free mentorship and knowledge exchange.
Join Bayer's Expert Mondays, dedicated to topics that can support you, your innovation, and your start-up in its growth! Benefit from Bayer´s global expertise, network with fellow founders and the Bayer Pharma team, and ask your questions. Let´s Collaborate to Cure!
Please note: These sessions are not intended for service providers, consultants, IT providers, etc., but are limited to drug developers and researchers in healthcare who are seeking collaboration with big pharma and out-licensing opportunities later in their journey.
| Date | Topic (mouse over for full description) |
Bayer Expert |
|
July 3 5 p.m. CEST |
Alternative Financing Possibilities: Creative Ways to Bridge the 'Valley of Death' |
Anett Müller BD&L Director Early Valuation |
|
July 17 5 p.m. CEST |
Medical Need: A Definition Challenge to Shape Your Value Proposition |
J.P. Kruse BD&L Senior Director |
|
July 31 5 p.m. CEST |
Gating Decisions and How to Take the Right Ones |
Dr. Hartwig Hennekes VP, Project Management Oncology |
|
Sept 4 5 p.m. CEST |
Spotlight on the Public/EU Grant Landscape |
Ina Kunze BD&L Director Funding EU |
|
Sept 18 5 p.m. CEST |
Your Roadmap through the EU Regulatory Jungle |
Dr. Isabelle Stoeckert VP, Head Regulatory Affairs EMEA Dr. Gabrielle Bräunlich Regulatory Affairs EMEA |
|
Sept 25 5 p.m. CEST |
Venture Capital, Investment Banks: Strategic Financial Investors like Big Pharma, what are they looking for? |
Vishal Patel BD&L Strategy |
|
Oct 9 5 p.m. CEST |
Why Early Market Access Planning is a Good Investment & 10-min. deep-dive on Cell & Gene |
Market Access Lead Franziska Gröhl Market Access Manager
Market Access Cell & Gene |
|
Oct 16 5 p.m. CEST |
Building a Credible Business Case |
Anett Müller BD&L Director Early Valuation |
|
Oct 23 5 p.m. CEST |
Leaps by Bayer: Funding the 10 Leaps |
André Guillaume Head of Brand & Community Engagement Leaps by Bayer |
| Date | Topic (mouse over for full description) |
Bayer Expert |
|
13 Nov 5 p.m. CET |
Business Process of Due Diligence @ Big Pharma: Why do they need so many documents & what´s in it for you?
|
Dr. Anja Moews |
|
27 Nov 5 p.m. CET |
How to Prepare a Non-Confidential Deck & Pitching Pitfalls to Avoid |
Sebastian Karrer Dr. Daniel Forler BD&L Senior Directors |
| Date | Topic (mouse over for full description) |
Bayer Expert |
|
Nov 6 BIO-Europe Munich, Germany |
Panel Session Recipes for Successful Biotech & Big Pharma Partnerships |
Speakers TBA |
|
Dec 4 5 p.m. CET |
How to Build and Maintain a Successful Partnership & Bayer's Partnership Models |
Dr. Christoph Huwe Dr. Hanna Eilken Senior Directors, Alliance Management |
| Date | Topic (mouse over for full description) |
Bayer Expert |
|
Dec 11 5 p.m. CET |
Bayer's Co.Labs: Incubators Around the World |
Fiona Mack VP, Head of Co.Lab Boston |
About Bayer's Collaborate To Cure Hubs
The Bayer Collaborate To Cure Hub EMEA organizes these knowledge-sharing sessions to boost and support innovation in the EMEA region. As the regional hub of Bayer Pharma’s Business Development & Licensing team, we also offer a partnering interface to Bayer’s global scouting teams.
Through the Collaborate To Cure Hubs, Bayer is looking for the best and brightest ideas and projects in their respective locations for collaborations, partnerships, in-licensing, co-development, and many other forms of collaboration.
Connect with us if you are interested in collaborating, and let’s collaborate to cure to bring innovation to patients!
